Sponsored by Ultragenyx Pharmaceutical Inc.
Variant ID | 462 |
---|---|
Genomic Coordinate (GRCh38) | g.22178293_22178294insGACT |
Variant | c.1503_1504insGACT |
Variant Start Position | 1503 |
Location | Exon 14 |
Amino Acid Change | p.Tyr502Aspfs*17 |
ACMG Call | - |
ACMG Call Last Revised Date | 4/28/2021 |
Predicted ACMG Call | Pathogenic | Effect Type | Frameshift |
Variant Type | Small insertion |
PMID | 24926462, 23079138, 16636593, 10439971, 34806794 |
Article Count | 5 |
Times Observed | < 3 |
Clinical Phenotype | abnormal bone development |
ACMG Categories | pvs1, pm2, ppc |
ACMG Explanations | pvs1: This is a loss of function variant. pm2: No frameshift variants were found in gnomAD exomes or genomes at this position. |
Variant in Clinvar | No |
ClinVar Classification | - |
Categories In Literature | ppc |
No Contrary Evidence Found | Yes |
ExAC Allele Frequency | - |
Thousand Genomes Allel Frequency | - |
Ontology Relations | - |
hg19 Mapping Failed | No |
Literature Alleles | - |
GnomAD Alleles | - |
DBNSFP Alleles | - |
Other Alleles | - |
Note | nan |
Warnings | - |